Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors

Menno Tamminga*, Sanne De Wit, T. Jeroen N. Hiltermann, Wim Timens, Ed Schuuring, Leon W.M.M. Terstappen, Harry J.M. Groen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

29 Citations (Scopus)
30 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences